130 Participants Needed

Milk Polar Lipids for Abdominal Obesity

CN
Overseen ByChristopher N Blesso, Ph.D.

Trial Summary

What is the purpose of this trial?

The major objective of this project is to examine whether daily consumption of milk polar lipids (MPLs) influences cardiometabolic risk factors.

Will I have to stop taking my current medications?

Yes, you will need to stop taking certain medications. The trial excludes people taking lipid-lowering medications, anti-inflammatory medications, and medications that affect blood clotting.

What data supports the effectiveness of the treatment Milk Polar Lipids for Abdominal Obesity?

Research shows that milk polar lipids, particularly those in the milk fat globule membrane (MFGM), have antioxidant and anti-inflammatory properties, which may help improve metabolic health. Additionally, MFGM has been shown to support cognitive development in infants and reduce colon cancer markers in rats, suggesting potential health benefits that could extend to managing abdominal obesity.12345

Is Milk Polar Lipids treatment safe for humans?

Milk Polar Lipids, found in milk fat globule membranes (MFGM), have been used in various products like infant formula and are generally considered safe. Studies have shown positive effects on cognitive and immune health, and they have antioxidant and anti-inflammatory properties, suggesting they are safe for human consumption.12467

How is the Milk Polar Lipid-Rich Dairy Powder treatment unique for abdominal obesity?

Milk Polar Lipid-Rich Dairy Powder is unique because it contains milk polar lipids, which have been shown to potentially improve gut health and reduce inflammation, factors that can contribute to obesity. Unlike other treatments, it leverages the natural properties of milk fat globule membrane components, which may help modulate gut bacteria and prevent weight gain in high-fat diets.148910

Eligibility Criteria

This trial is for adults aged 40 to 70 with high LDL cholesterol (bad cholesterol) and a large waistline, indicating abdominal obesity. It's not suitable for individuals with gallbladder, thyroid, gut diseases, autoimmune or chronic inflammatory conditions, diabetes, recent antibiotic use, milk allergies/intolerances, or those on certain medications like statins.

Inclusion Criteria

Your LDL cholesterol level is higher than 130 mg/dL.
Your waist measurement is 88 cm or more if you are a woman, or 102 cm or more if you are a man.
I am between 40 and 70 years old.

Exclusion Criteria

I have a thyroid condition.
You are allergic or intolerant to milk products.
You have an eating disorder.
See 21 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants consume either a control dairy beverage or an MPL-rich dairy beverage daily

8 weeks
Weekly check-ins (virtual or in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

Treatment Details

Interventions

  • Dairy Powder
  • Milk Polar Lipid-Rich Dairy Powder
Trial Overview The study tests if consuming a dairy powder rich in milk polar lipids daily can improve heart health and reduce risk factors associated with heart disease in people with high cholesterol and abdominal obesity.
Participant Groups
2Treatment groups
Experimental Treatment
Placebo Group
Group I: MPL-rich dairy powderExperimental Treatment1 Intervention
Daily consumption of 50 g of dairy powder containing 6.5 g MPL for 8 weeks.
Group II: Control dairy powderPlacebo Group1 Intervention
Daily consumption of 50 g of dairy powder containing \<0.1 g MPL for 8 weeks

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Connecticut

Lead Sponsor

Trials
194
Recruited
162,000+

Dairy Management Inc.

Industry Sponsor

Trials
21
Recruited
2,600+

Findings from Research

A new method was developed to enrich polar lipids from milk by-products, specifically from whey protein concentrate, resulting in a fraction containing 38.56% phospholipids, which can enhance the nutritional value of food products.
The enriched polar lipid fraction demonstrated significant antioxidant properties, increasing the oxidation stability of fish oil by over 30 times and reducing inflammation markers (IL-6 and TNF-α) in cell cultures, suggesting potential health benefits in functional foods.
Preparation and Characterization of a Polar Milk Lipid-enriched Component from Whey Powder.Lee, K., Kim, A., Hong, KB., et al.[2020]
Supplementing obese rat dams with polar lipids-enriched milk fat globule membrane (MFGM-PL) during pregnancy and lactation significantly improves the skeletal growth of their male offspring, particularly at weaning.
In adulthood, MFGM-PL supplementation protects against bone degeneration and enhances insulin sensitivity in offspring, likely by boosting the growth hormone/insulin-like growth factor-1 (GH/IGF-1) axis, indicating long-term benefits for skeletal health.
Milk Polar Lipids Supplementation to Obese Rats During Pregnancy and Lactation Benefited Skeletal Outcomes of Male Offspring.Han, L., Du, M., Ren, F., et al.[2022]
In a study involving male Fischer-344 rats, those fed a diet containing milk fat globule membrane (MFGM) showed significantly fewer aberrant crypt foci (ACF), a marker of colon cancer risk, compared to those fed diets with corn oil or anhydrous milk fat, suggesting MFGM may have protective effects against colon carcinogenesis.
Despite the observed reduction in ACF with MFGM, gene expression analysis did not show changes in colon cancer-related genes, indicating that the mechanism of protection may not involve direct alterations in gene expression or sphingolipid profiles in the colonic mucosa.
Dietary milk fat globule membrane reduces the incidence of aberrant crypt foci in Fischer-344 rats.Snow, DR., Jimenez-Flores, R., Ward, RE., et al.[2020]

References

Preparation and Characterization of a Polar Milk Lipid-enriched Component from Whey Powder. [2020]
Milk Polar Lipids Supplementation to Obese Rats During Pregnancy and Lactation Benefited Skeletal Outcomes of Male Offspring. [2022]
Dietary milk fat globule membrane reduces the incidence of aberrant crypt foci in Fischer-344 rats. [2020]
Effects of milk fat globule membrane and its various components on neurologic development in a postnatal growth restriction rat model. [2020]
Advancement on Milk Fat Globule Membrane: Separation, Identification, and Functional Properties. [2023]
Lipidomic and Proteomic Profiling of the Milk Fat Globule Membrane from Different Industrial By-Products of the Butter and Butter Oil Manufacturing Process. [2023]
Omics analysis reveals variations among commercial sources of bovine milk fat globule membrane. [2020]
Milk Polar Lipids: Underappreciated Lipids with Emerging Health Benefits. [2023]
Milk Polar Lipids in a High-Fat Diet Can Prevent Body Weight Gain: Modulated Abundance of Gut Bacteria in Relation with Fecal Loss of Specific Fatty Acids. [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
Thermocalcic aggregation of milk fat globule membrane fragments from acid buttermilk cheese whey. [2020]